Thank you!
Thank you to everyone who attended the Discngine Meetup this year!
Innovative strategies for biotherapeutic developability assessment
About the event
Once a year, we host the Discngine Meetup event - a dynamic interdisciplinary gathering at the interface between science and IT in drug discovery. This year’s theme, “Innovative strategies for biotherapeutic developability assessment,” includes insightful talks and interactive sessions led by industry experts.
Predicting developability profiles of novel biotherapeutics can greatly de-risk projects, reduce timelines, and save resources. Our speakers will present early-stage approaches and innovative technologies for developability assessment. They will discuss in-silico workflows and advanced in-vitro methods that guide decision-making toward selecting the most optimal drug candidate.
By attending this two-hour virtual event, you will gain insights into effective strategies and solutions to address the ongoing challenges in this progressing field.
Plenary Session
Towards biologics by design: AI-driven optimization of next generation NANOBODY® therapeutics
Norbert Furtmann, Ph.D.
Group Leader & Head of AI Innovation NANOBODY® Platform at Sanofi
The recording will be provided upon approval!
Talk session
3dpredict: Addressing Antibody Property Predictions at Scale
Eric Le Roux
CEO at Discngine
Peter Schmidtke, Ph.D.
Scientific Project Manager at Discngine
Round table
Cutting-Edge Technologies and Tactics for Advancing Biotherapeutic Drug Discovery
Per Greisen, Ph.D.
President & Head of Protein Design at BioMap
Matthew Raybould, Ph.D.
Postdoctoral Researcher in the Oxford Protein Informatics Group at University of Oxford
Essam Metwally, Ph.D.
Principal Scientist / Scientific Director at MSD
Nels Thorsteinson, Ph.D.
Director of Biologics at Chemical Computing Group
